• Mashup Score: 11

    Bakouny et al. perform integrative genomic analyses of MiT/TFE-translocation renal cell carcinoma (tRCC) to define the hallmarks of this rare form of kidney cancer. They find that tRCC harbors few recurrent genomic alterations, is characterized by NRF2 activation, and is resistant to targeted therapies but may show responses to immunotherapy.

    Tweet Tweets with this article
    • Integrative clinical and molecular characterization of translocation renal cell carcinoma - read the full article by @srviswanathan @DanaFarber @Harvardmed & others in @CellReports #AACR23 https://t.co/VXbXzoOwuQ

  • Mashup Score: 3

    Knudsen et al. find that there is extensive heterogeneity in the requirement for CDK and cyclins across cancer models. Multiple biochemically distinct mechanisms drive cell division. Divergent cell-cycle states harbor distinct genetic and pharmacological vulnerabilities, suggesting that cell-cycle diversity could be exploited for a precision approach to cancer therapy.

    Tweet Tweets with this article
    • Check out this collaboration by @RoswellPark faculty members Agnieszka Witkiewicz & Erik Knudsen "CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities" published in @CellReports #AACR23 https://t.co/6h9hbGksRD